Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
Clinical trial NCT06463548 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06463548
- Sponsor
- Yunpeng Liu
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.